HCPCS J9326
Telisotuzumab vedotin-tllv
HCPCS J9326 at a glance
- Code
- J9326
- Code type
- CPT/HCPCS
- Short descriptor
- Telisotuzumab vedotin-tllv
- Category
- ASC Ancillary
- ASC payment status
- Payable in an ASC (ancillary)
- CMS addendum
- BB (Ancillary)
- Typical setting
- Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
What is HCPCS code J9326?
HCPCS J9326 is a CPT/HCPCS procedure code. Its official CMS short descriptor is "Telisotuzumab vedotin-tllv". In the ASC context it is grouped under ASC Ancillary.
Is HCPCS J9326 payable in an ambulatory surgery center (ASC)?
HCPCS J9326 is a covered ancillary service (CMS Addendum BB). Medicare reimburses it in the ASC setting when it is integral to a covered ASC surgical procedure.
Where is HCPCS J9326 typically performed?
Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
Reference information compiled from the CMS April 2026 ASC payment addenda (AA, BB, EE). Codes, descriptors, and ASC payment status change with each CMS update. This is a coding reference, not billing, coding, or legal advice. Always verify against the current CMS addenda and individual payer policy before billing. CPT is a registered trademark of the American Medical Association.